Antibiotic injection in pharma franchise in Imphal

Antibiotic injection in PCD pharma franchise in Gujarat

Antibiotic injection in top pharma company in Lucknow

Antibiotic injection in pcd pharma supplier in Vadodara

Antibiotic injection in phama franchise company in india
Antibiotic injection of Iron syrup in phama distributor in Amritsar

Home/Products /l-ornithine-l-aspartate-5gm-injection

About the Product

Description


Hepalogy L contains L-Ornithine L-Aspartate (5gm), a powerful hepatic detoxifier used in the management of liver disorders. It plays a crucial role in reducing ammonia levels in the blood, which helps in the treatment of conditions like hepatic encephalopathy, liver cirrhosis, fatty liver, and other liver-related complications. By supporting the urea cycle, it promotes ammonia detoxification and enhances liver function.

L-Ornithine L-Aspartate is essential for cellular metabolism and liver regeneration, helping to restore liver health by supporting protein synthesis and energy production. It works by converting toxic ammonia into urea, which is then excreted through the kidneys, reducing the burden on the liver. Additionally, it aids in reducing fatigue, improving digestion, and enhancing overall well-being in individuals with compromised liver function.

Hepalogy L is commonly recommended for individuals suffering from chronic liver diseases, alcohol-induced liver damage, and fatty liver disease. It also helps alleviate mental confusion and lethargy associated with hepatic encephalopathy. Regular supplementation under medical supervision supports liver health, enhances detoxification, and improves overall metabolic function.

This formulation is easy to administer and is typically taken by dissolving the prescribed dose in water, ensuring quick absorption and effectiveness.

Mild side effects may include nausea, diarrhea, stomach discomfort, and bloating. Serious side effects are rare but should be reported to a doctor if experienced.

Hepalogy L is used for the management of hepatic encephalopathy, liver cirrhosis, fatty liver disease, and hyperammonemia.

Use under medical supervision. Do not exceed the recommended dose. Patients with kidney dysfunction should consult their doctor before use.

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for L-Ornithine L-Aspartate 5gm Injection in the PCD pharma franchise market?

L-Ornithine L-Aspartate 5gm Injection has strong demand in the hepatology, critical care, and hospital segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on liver-care and institutional healthcare portfolios.

Why should medical distributors include L-Ornithine L-Aspartate 5gm Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for liver-supportive therapy under specialist supervision. L-Ornithine L-Aspartate (LOLA) helps support ammonia detoxification and liver metabolism Commonly used in the management of hepatic disorders and liver-related complications as prescribed by healthcare professionals Injectable formulation is preferred in hospital and critical-care settings where rapid administration is required This strengthens a specialized hepatology and hospital-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this injection?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for L-Ornithine L-Aspartate 5gm Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from hospital demand, physician and gastroenterologist prescriptions, institutional supply opportunities, reliable supply chain support, and good margins in specialty injectable medicines.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality products, and a dependable supply chain to grow their pharmaceutical business successfully.